Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.
作者信息
Imafuku Tadashi, Watanabe Hiroshi, Oniki Kentaro, Yoshida Akira, Kato Hiromasa, Nakano Takehiro, Tokumaru Kai, Fujita Issei, Arimura Nanaka, Maeda Hitoshi, Sakamoto Yuki, Kondo Nozomi, Morita Ayami, Saruwatari Junji, Tanaka Motoko, Matsushita Kazutaka, Wada Takashi, Fukagawa Masafumi, Otagiri Masaki, Fitzgerald Michael L, Jinnouchi Hideaki, Maruyama Toru
机构信息
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
Lipid Metabolism Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA.
出版信息
Diabetes Care. 2021 Jun;44(6):e115-e117. doi: 10.2337/dc20-3003. Epub 2021 Apr 26.
Abstract
摘要
Zotero 插件